[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2019-002113-19"
            },
            {
                "name": "Study Protocol Other Identifier",
                "value": "42756493CAN2002"
            }
        ],
        "amendment_date": null,
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Janssen Research & Development, LLC",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Histologic demonstration of an unresectable, locally advanced, or metastatic solid tumor malignancy with an fibroblast growth factor receptor (FGFR) mutation or FGFR gene fusion"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Measurable disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Participant must have received at least one prior line of systemic therapy in the advanced, unresectable, or metastatic setting; or is a child or adolescent participant with a newly-diagnosed solid tumor and no acceptable standard therapies"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Documented progression of disease, defined as any progression that requires a change in treatment, prior to full study screening"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 4,
                    "description": "Has had prior chemotherapy, targeted therapy, or treatment with an investigational anticancer agent within 15 days or less than or equal to (<=) 5 half-lives of the agent (whichever is longer) and up to a maximum of 30 days before the first dose of erdafitinib"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 5,
                    "description": "The presence of FGFR gatekeeper and resistance mutations"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 6,
                    "description": "Histologic demonstration of urothelial carcinoma"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 7,
                    "description": "Hematologic malignancy (i.e., myeloid and lymphoid neoplasms"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 8,
                    "description": "For non-small cell lung cancer participants only: pathogenic somatic mutations or gene fusions in the following genes: EGFR, ALK, ROS1, NTRK, BRAF V600E and KRAS"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Active malignancies other than for disease requiring therapy"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "6 Years",
                "min_age_number": 6.0,
                "min_age_in_years": 6.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "Erdafitinib is a selective and potent pan FGFR 1-4 inhibitor with demonstrated clinical\r\n      activity in participants with metastatic urothelial cancer and cholangiocarcinoma identified\r\n      to have alterations in the FGFR pathway. This study targets the underlying altered biology of\r\n      FGFR-driven tumors irrespective of solid tumor histology subtype. The study consists of\r\n      screening phase, treatment phase and the post treatment follow-up phase (from the end of\r\n      treatment visit until the participants has died, withdraws consent, is lost to follow-up, or\r\n      the end of study, whichever comes first). End of study is defined as 4 years from enrollment\r\n      of last participant into study or last follow-up visit of last participant, whichever occurs\r\n      first.",
        "official_title": "A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations",
        "_phase_sort_order": 2,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Baseline; up to 6 years and 9 months",
                "name": "Change from Baseline in Health-Related Quality of Life as Assessed by European Quality of Life - 5 Dimensions-5 Levels (EQ-5D-5L) Scale Score",
                "description": "The EQ-5D-5L is a generic measure of health status. The EQ-5D-5L is a 5-item questionnaire that assesses 5 domains including mobility, self-care, usual activities, pain/discomfort and anxiety/depression plus a visual analog scale rating \"health today\" with anchors ranging from 0 (worst imaginable health state) to 100 (best imaginable health state).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline; up to 6 years and 9 months",
                "name": "Change from Baseline in Health-Related Quality of Life as Assessed by Patient Global Impression of Change (PGIC) Scale",
                "description": "The PGIC is the patient-reported outcome (PRO) counterpart to the clinical global impressions (CGI) scale. The PGIC is a single verbal rating scale ranging from 1 = a lot better now to 7 = a lot worse now.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline; up to 6 years and 9 months",
                "name": "Change from Baseline in Health-Related Quality of Life as Assessed by Patient Global Impression of Symptom Severity (PGIS) Scale Score",
                "description": "The PGIS is a single question regarding the patient report of disease severity: considering all aspects of your cancer symptoms right now would you say your cancer symptoms are none, mild, moderate, severe, or very severe?",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline; up to 6 years and 9 months",
                "name": "Change from Baseline in Health-Related Quality of Life (HRQoL) as Assessed by European Organisation for Research and Treatment of Cancer Quality-of-life Questionnaire Core 30 (EORTC-QLQ-C30) Scale Score",
                "description": "The EORTC QLQ-C30 includes 30 items in 5 functional scales, 1 global health status scale, 3 symptom scales, and 6 single symptom items. The responses are reported using a verbal rating scale. The item and scale scores are transformed to a 0 to 100 scale. A higher score represents greater HRQoL, better functioning, and more (worse) symptoms.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline; up to 6 years and 9 months",
                "name": "Change from Baseline in Pediatric Functional Assessment of Cancer Therapy - Brain (Peds FACT-Br) Total Score",
                "description": "Peds FACT-Br consists of 4 sets of disease-specific questions pertaining to brain neoplasms (a set of 34 to 37 questions each for child, parent of child, adolescent or parent of adolescent). Peds FACT-Br total score for child ranges from 0-136 and for parent of child, adolescent and parent of adolescent the score ranges from 0-148. Here '0' indicates a severely \"symptomatic participant\" and highest score indicates \"asymptomatic participant\".",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Clinical Benefit Rate (CBR)",
                "description": "CBR is defined as the percentage of participants with CR, PR or durable SD.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Disease Control Rate (DCR)",
                "description": "DCR is defined as the percentage of participants with CR, PR or stable disease (SD).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Duration of Response (DOR)",
                "description": "DOR is the duration from the date of initial documentation of a response to the date of first documented evidence of progressive disease (or relapse for participants who experience CR during the study), or death, whichever comes first.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Number of Participants with Adverse Events (AEs)",
                "description": "An AE is any untoward medical occurrence in a clinical study participant administered a medicinal (investigational or non-investigational) product. An adverse event does not necessarily have a causal relationship with the relevant investigational product.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Number of Participants with Adverse Events by Severity",
                "description": "An AE is any untoward medical occurrence in a clinical study participant administered a medicinal (investigational or non-investigational) product. Adverse event severity is a clinical determination of the intensity of an adverse event.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Overall Response Rate as Assessed by Investigator",
                "description": "ORR as assessed by investigator is defined as the percentage of participants who achieve a CR or PR.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Overall Response Rate (ORR) as Assessed by Independent Review Committee (IRC)",
                "description": "ORR as assessed by IRC is defined as the percentage of participants who achieve a complete response (CR) or partial response (PR).",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Overall Survival (OS)",
                "description": "OS will be measured from the date of first dose of study drug to the date of the participant's death.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Predose and 2-4 hours postdose",
                "name": "Plasma Concentrations of Erdafitinib",
                "description": "Plasma concentrations of erdafitinib will be reported.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 6 years and 9 months",
                "name": "Progression Free Survival (PFS)",
                "description": "PFS is the duration from the date of the first dose of study drug until the date of first documented evidence of progressive disease (or relapse for participants who experience CR during the study) or death, whichever comes first.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04083976",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "FGFR Alteration",
                    "FGFR Alteration Positive",
                    "Fibroblast Growth Factor Receptor Alteration",
                    "Fibroblast Growth Factor Receptor Alteration Positive",
                    "Fibroblast Growth Factor Receptor Family Alteration",
                    "Fibroblast Growth Factor Receptor Family Alteration Positive"
                ],
                "nci_thesaurus_concept_id": "C133705",
                "name": "FGFR Family Alteration Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C19930",
                    "C3367",
                    "C20103",
                    "C16612",
                    "C25870",
                    "C25872",
                    "C77140",
                    "C25871",
                    "C20719",
                    "C35682",
                    "C36292",
                    "C21295",
                    "C21281"
                ],
                "parents": [
                    "C19930",
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "FGF Receptor Gene Family Mutation",
                    "FGF Receptor Gene Mutation",
                    "FGFR Family Gene Mutation",
                    "FGFR Family Mutation",
                    "FGFR Mutation",
                    "Fibroblast Growth Factor Receptor Family Gene Mutation",
                    "Fibroblast Growth Factor Receptor Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C146713",
                "name": "FGFR Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25872",
                    "C16612",
                    "C36391",
                    "C20103",
                    "C20719",
                    "C21281",
                    "C21295",
                    "C36327",
                    "C19930",
                    "C3910",
                    "C25871",
                    "C97926",
                    "C141240",
                    "C25870"
                ],
                "parents": [
                    "C141240",
                    "C19930",
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Fusion Detected",
                    "Fusion Positive",
                    "Gene Fusion Detected",
                    "Gene Fusion Positive"
                ],
                "nci_thesaurus_concept_id": "C177683",
                "name": "Genetic Fusion Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C77140",
                    "C103223",
                    "C3367",
                    "C158948",
                    "C36292",
                    "C35682"
                ],
                "parents": [
                    "C103223",
                    "C158948"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C103223",
                "name": "Genetic Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "FGF Receptor Gene Family Fusion Positive",
                    "FGF Receptor Gene Fusion Positive",
                    "FGFR Gene Family Fusion Positive",
                    "Fibroblast Growth Factor Receptor Gene Family Fusion Positive",
                    "Fibroblast Growth Factor Receptor Gene Fusion Positive"
                ],
                "nci_thesaurus_concept_id": "C132244",
                "name": "FGFR Gene Fusion Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25872",
                    "C20719",
                    "C16612",
                    "C77140",
                    "C133705",
                    "C3367",
                    "C103223",
                    "C158948",
                    "C25870",
                    "C36292",
                    "C25871",
                    "C21295",
                    "C20103",
                    "C19930",
                    "C35682",
                    "C177683",
                    "C21281"
                ],
                "parents": [
                    "C133705",
                    "C177683",
                    "C19930"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36391",
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "RTK Family Gene Mutation",
                    "RTK Family Mutation",
                    "RTK Gene Mutation",
                    "Receptor Tyrosine Kinase Family Gene Mutation",
                    "Tyrosine Kinase Receptor Family Mutation",
                    "Tyrosine Kinase Receptor Gene Mutation",
                    "Tyrosine Kinase Receptor Mutation"
                ],
                "nci_thesaurus_concept_id": "C141240",
                "name": "Receptor Tyrosine Kinase Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25872",
                    "C16612",
                    "C36391",
                    "C20103",
                    "C20719",
                    "C21281",
                    "C36327",
                    "C21295",
                    "C3910",
                    "C25871",
                    "C97926",
                    "C25870"
                ],
                "parents": [
                    "C20719",
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "FGF Receptor Family Gene",
                    "FGFR Family Gene"
                ],
                "nci_thesaurus_concept_id": "C19930",
                "name": "Fibroblast Growth Factor Receptor Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25872",
                    "C16612",
                    "C20103",
                    "C20719",
                    "C21281",
                    "C21295",
                    "C25871",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal Rearrangement Detected",
                    "Chromosome Rearrangement Detected",
                    "Cytogenetic Rearrangement Detected",
                    "Cytogenetic Rearrangement Positive",
                    "Cytogenetic Rearrangement Present",
                    "Rearrangement Positive",
                    "Rearrangement Present",
                    "Rearrangement identified"
                ],
                "nci_thesaurus_concept_id": "C158948",
                "name": "Rearrangement Detected",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C35682",
                    "C77140"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2019-11-20",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C148036",
                "name": "Unresectable Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C132146",
                    "C127156"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "Locally advanced",
                    "regional cancer",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127156",
                "name": "Unresectable Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "CR108661",
        "active_sites_count": 8,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmaceuticals",
                            "Drug Substance",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Balversa"
                        ],
                        "nci_thesaurus_concept_id": "C103273",
                        "name": "Erdafitinib",
                        "description": "An orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity. Upon oral administration, JNJ-42756493 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways and thus the inhibition of tumor cell proliferation and tumor cell death in FGFR-overexpressing tumor cells. FGFR, upregulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cell proliferation, differentiation and survival.  Check for active clinical trials or closed clinical trials using this agent.Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1967",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Protein Tyrosine Kinase Inhibitors",
                            "PTK Inhibitors",
                            "TK Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C1967",
                        "name": "Tyrosine Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Erdafitinib",
                "description": "Participants with fibroblast growth factor receptor (FGFR) mutations and FGFR gene fusions will receive a dose of erdafitinib oral tablets until disease progression, intolerable toxicity, withdrawal of consent, or decision by the investigator to discontinue treatment.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-07959",
        "why_study_stopped": null,
        "brief_summary": "The purpose of this study is to evaluate the efficacy of erdafitinib in terms of overall\r\n      response rate (ORR) in adult and pediatric participants with advanced solid tumors with\r\n      fibroblast growth factor receptor (FGFR) alterations (mutations or gene fusions). It will\r\n      also evaluate ORR in pediatric participants with advanced solid tumors and FGFR alterations.",
        "brief_title": "A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations",
        "status_history": [
            {
                "status_date": "2019-11-20T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2019-11-07T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 336,
        "_current_trial_status_sort_order": 0,
        "start_date": "2019-11-20",
        "record_verification_date": "2022-03-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2028-12-04",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]